Search Research Articles
Browse Research Categories

PE-22-28 Peptide Research

PE-22-28 is a synthetic peptide fragment studied for its fast-acting antidepressant and anxiolytic properties through a novel mechanism involving modulation of the TREK-1 two-pore domain potassium channel and downstream BDNF-related signaling. Research suggests PE-22-28 may produce rapid mood-stabilizing effects through pathways distinct from classical antidepressants, with potential relevance to treatment-resistant depression. Studies have also explored its neuroprotective and neuroplasticity-enhancing properties. As a research peptide targeting novel depression mechanisms, it represents a promising area of study. This section covers scientific studies on PE-22-28 and its neurological, antidepressant, and mental health peptide research applications.

Other Popular Research Categories

Newest PE-22-28 Research

PE-22-28 Peptide Research – Complete Guide

PE-22-28 is a synthetic seven-amino-acid peptide derived from spadin, studied in preclinical models for its potent inhibition of the TREK-1 potassium channel, a mechanism distinct from conventional antidepressants. This guide covers PE-22-28 peptide research across depression, neurogenesis, cognitive enhancement, and neuroprotection models, including molecular properties, mechanisms of action, pharmacokinetics, and current regulatory status. All information is drawn from preclinical research;...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0